DEFINITIVE HEALTHCARE CORP (DH) Forecast, Price Target & Analyst Ratings

NASDAQ:DHUS24477E1038

Current stock price

1.1 USD
+0.02 (+1.85%)
At close:
1.1 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DEFINITIVE HEALTHCARE CORP (DH).

Forecast Snapshot

Consensus Price Target

Price Target
$2.82
+ 156.73% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 30, 2026
Period
Q1 / 2026
EPS Estimate
$0.03
Revenue Estimate
57.08M

ChartMill Buy Consensus

Rating
75.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$2.82
Upside
+ 156.73%
From current price of $1.10 to mean target of $2.82, Based on 20 analyst forecasts
Low
$1.92
Median
$2.93
High
$4.20

Price Target Revisions

1 Month
-29.12%
3 Months
-28.29%

Price Target Summary

20 Wall Street analysts provided a forecast for the next 12 months for DH. The average price target is 2.82 USD. This implies a price increase of 156.73% is expected in the next year compared to the current price of 1.1.
The average price target has been revised downward by 28.29% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

DH Current Analyst RatingDH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

DH Historical Analyst RatingsDH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
75.00%
DH was analyzed by 20 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about DH.
In the previous month the buy percentage consensus was at a similar level.
DH was analyzed by 20 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-30BarclaysMaintains Underweight -> Underweight
2026-02-27Stephens & Co.Maintains Equal-Weight -> Equal-Weight
2026-02-27Canaccord GenuityMaintains Hold -> Hold
2025-12-09BarclaysMaintains Underweight -> Underweight
2025-11-10Canaccord GenuityMaintains Hold -> Hold
2025-08-08StifelMaintains Buy -> Buy
2025-05-12Goldman SachsMaintains Neutral -> Neutral
2025-03-04Goldman SachsMaintains Neutral -> Neutral
2025-03-03BarclaysMaintains Underweight -> Underweight
2025-01-16NeedhamReiterate Hold -> Hold
2025-01-13BarclaysDowngrade Equal-Weight -> Underweight
2024-12-20Stephens & Co.Initiate Equal-Weight
2024-11-08NeedhamReiterate Hold
2024-09-17BTIGInitiate Buy
2024-08-09Deutsche BankMaintains Hold -> Hold
2024-08-07BarclaysMaintains Equal-Weight -> Equal-Weight
2024-08-07BairdMaintains Neutral -> Neutral
2024-08-06NeedhamReiterate Hold
2024-08-06Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2024-07-31NeedhamReiterate Hold
2024-07-31StifelMaintains Buy -> Buy
2024-07-31BarclaysMaintains Equal-Weight -> Equal-Weight
2024-07-31JP MorganDowngrade Neutral -> Underweight
2024-07-31BairdMaintains Neutral -> Neutral
2024-05-09Deutsche BankMaintains Hold -> Hold

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 30, 2026
Period
Q1 / 2026
EPS Estimate
$0.03
Revenue Estimate
57.08M
Revenue Q2Q
-3.57%
EPS Q2Q
-32.43%
Number of Analysts
14

Next Earnings Revisions

Revenue (1 Month)
-3.16%
Revenue (3 Months)
-3.58%
EPS (1 Month)
-44.51%
EPS (3 Months)
-45.51%

Next Earnings Summary

DH is expected to report earnings on 4/30/2026. The consensus EPS estimate for the next earnings is 0.03 USD and the consensus revenue estimate is 57.08M USD.
The next earnings revenue estimate has been revised downward by 3.58% in the past 3 months.

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
DH revenue by date.DH revenue by date.
251.415M
12.89%
252.202M
0.31%
241.521M
-4.24%
230.32M
-4.64%
231.01M
0.30%
248.3M
7.48%
EBITDA
YoY % growth
DH ebitda by date.DH ebitda by date.
20.839M
0.19%
41.926M
101.19%
39.497M
-5.79%
62.037M
57.07%
64.375M
3.77%
40.848M
-36.55%
EBIT
YoY % growth
DH ebit by date.DH ebit by date.
-30.911M
14.37%
-9.741M
68.49%
-16.613M
-70.55%
46.38M
379.18%
47.625M
2.68%
3.649M
-92.34%
Operating Margin
DH operating margin by date.DH operating margin by date.
-12.29%-3.86%-6.88%20.14%20.62%1.47%
EPS
YoY % growth
DH eps by date.DH eps by date.
0.30
25.00%
0.35
16.67%
0.25
-28.57%
0.21
-16.10%
0.23
9.88%
0.25
7.26%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.03
-32.43%
0.04
-38.94%
0.04
-36.43%
0.05
-20.00%
0.05
44.82%
0.05
26.51%
0.06
27.31%
0.06
18.03%
Revenue
Q2Q % growth
57.08M
-3.57%
57.404M
-5.51%
57.519M
-4.21%
58.839M
-4.38%
56.344M
-1.29%
57.45M
0.08%
57.474M
-0.08%
58.811M
-0.05%
EBITDA
Q2Q % growth
14.055M
86.98%
15.029M
-39.05%
15.5M
-63.20%
16.424M
-66.75%
14.955M
6.40%
15.559M
3.53%
16.077M
3.72%
17.362M
5.71%
EBIT
Q2Q % growth
10.804M
271.49%
11.518M
429.27%
12.069M
12,169.00%
12.414M
284.87%
11.257M
4.19%
11.738M
1.91%
12.979M
7.54%
13.391M
7.87%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

DH Yearly Revenue VS EstimatesDH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M 250M
DH Yearly EPS VS EstimatesDH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.1 0.2 0.3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-0.37%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
0.24%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-11.92%
EBIT Next 5 Year
N/A

DEFINITIVE HEALTHCARE CORP / DH Forecast FAQ

What do analysts expect the price target to be for DEFINITIVE HEALTHCARE CORP (DH)?

20 analysts have analysed DH and the average price target is 2.82 USD. This implies a price increase of 156.73% is expected in the next year compared to the current price of 1.1.

When does DEFINITIVE HEALTHCARE CORP (DH) report earnings?

DEFINITIVE HEALTHCARE CORP (DH) will report earnings on 2026-04-30.

What are the consensus estimates for DH stock next earnings?

The consensus EPS estimate for the next earnings of DEFINITIVE HEALTHCARE CORP (DH) is 0.03 USD and the consensus revenue estimate is 57.08M USD.

Can you provide the consensus rating for DEFINITIVE HEALTHCARE CORP stock?

The consensus rating for DEFINITIVE HEALTHCARE CORP (DH) is 75 / 100 . This indicates that analysts generally have a positive outlook on the stock.